Leiomyosarcoma (LMS) Terminated Phase 2 Trials for Deoxycholic acid (DB03619)

Also known as: LMS - Leiomyosarcoma / Leiomyosarcomas / Leiomyosarcoma / Leiomyosarcoma (morphologic abnormality) / Leiomyosarcoma NOS / Leiomyosarcoma (disorder)

IndicationStatusPhase
DBCOND0118909 (Leiomyosarcoma (LMS))Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT05116683
ATX-101 in Advanced Dedifferentiated Liposarcoma and LeiomyosarcomaTreatment